Clinical Trial Update: Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating everolimus in combination with cyclosporine microemulsion in de novo kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Everolimus (everolimus)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED